BCHE and Alzheimer disease: Based on the cholinergic hypothesis that assumes the increase in the acetylcholine (ACh) level, carbamate-like drugs can be regarded as one of the mainstays for the contemporary pharmacotherapy for Alzheimer’s disease (AD) by inhibiting cholinesterases (ChEs) [10].